KMT5A and Miyoshi myopathy: To demonstrate that SETD8 is indeed required for growth and viability of malignant plasma cells, bone marrow (BM) cells isolated from two healthy donors and from eight MM patients were cultured with recombinant interleukin 6 in presence or not of UNC-0379.